Tag: Bureau of Competition

Displaying 161 - 180 of 386 results.

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Honeywell International, Inc.’s acquisition of rival scan engine manufacturer Intermec Inc. was anticompetitive. The FTC’s complaint charged that the proposed acquisition would reduce...
The market for fuel ethanol in the United States is unconcentrated, with 156 firms nationwide either producing ethanol or likely to begin producing ethanol in the next 12 to 18 months, according to the Federal Trade Commission’s 2013 Report on the State of U.S. Ethanol Production. The lack of...
The Federal Trade Commission has extended the deadline for public comments on its proposed study of patent assertion entities (PAEs), which it announced on September 27.  To provide additional time for interested parties to submit comments on the proposed study, the deadline has been extended...
Following a public comment period, the Federal Trade Commission has approved an application by Pinnacle Entertainment, Inc. to divest all of the assets associated with Ameristar Casinos, Inc.’s casino and hotel project under construction in Lake Charles, Louisiana to GNLC Holdings, Inc., the...
Federal Trade Commission staff submitted a response to a request from the Public Service Commission of the State of Delaware for comments on a proposal to revise its rules for certifying and regulating electricity suppliers.
In testimony presented to a U.S. House of Representatives Judiciary subcommittee the Federal Trade Commission described its ongoing efforts to protect competition and consumers in many important sectors of the economy, including health care, pharmaceuticals, and technology.
The Federal Trade Commission held a workshop to explore competition issues involving biologic medicines and follow-on biologics. As described in the Federal Register Notice, the workshop focused on a few key issues, inter alia:
The Federal Trade Commission will host a one-day public workshop on December 10, 2013, at its headquarters in Washington, DC, to examine competition issues surrounding biologic and follow-on biologic medications.
The Federal Trade Commission issued final changes to the premerger notification rules that require companies in the pharmaceutical industry to report certain proposed acquisitions of exclusive patent rights to the FTC and the Department of Justice for antitrust review.
The Federal Trade Commission has unanimously voted to close its seven-month investigation into the proposed $1.2 billion merger of office supply superstores Office Depot, Inc. and OfficeMax, Inc. and has issued a Commission statement detailing the basis for its decision.
The Federal Trade Commission has approved a request by Kinder Morgan, Inc., that the Commission modify the final FTC order and approve a change to a related divestiture agreement.  The order resolved Commission charges that Kinder Morgan’s 2012 acquisition of El Paso Corporation would harm...
In light of the recent, temporary government shutdown, the Federal Trade Commission is extending the public comment periods for 13 matters that currently are pending before the agency in order to ensure that interested parties have a full opportunity to file comments.  The Commission also...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Solera Holdings, Inc.’s 2012 purchase of rival Actual Systems of America, Inc. was anticompetitive. The FTC's complaint alleges that the acquisition significantly harmed competition in...
International drug manufacturer Actavis, Inc. has agreed to sell all rights and assets to four generic pharmaceuticals – three oral contraceptives and an osteoporosis treatment – to settle FTC charges that its proposed $8.5 billion acquisition of drug-maker Warner Chilcott plc would be...
The Federal Trade Commission will require Mylan, Inc., and Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. (collectively, Agila) to divest 11 generic injectable drugs as a condition of allowing Mylan’s proposed acquisition of Agila from Strides Arcolab Ltd. (Strides).
The Federal Trade Commission is seeking public comment on an application by Polypore International, Inc. for approval to divest all stock and assets related to Microporous, which it acquired in February 2008, to Seven Mile Capital Partners (Seven Mile).  The divestiture is required by a Commission...
[corrected] Media research company Nielsen Holdings N.V. has agreed to settle Federal Trade Commission charges that its proposed acquisition of Arbitron Inc. may substantially lessen competition.  Nielsen will divest and license assets and intellectual property needed to develop national...
The Federal Trade Commission is seeking public comment on an application by Pinnacle Entertainment, Inc. for approval to divest its Lumiere Place Casino, two hotels, and all associated assets in St. Louis, Missouri, to Tropicana St. Louis LLC, a wholly owned subsidiary of Tropicana Entertainment,...
The Federal Trade Commission will require Honeywell International Inc. to license patents critical to the manufacture of two-dimensional (2D) bar code scanners, under a settlement resolving FTC charges that Honeywell’s acquisition of rival scan engine manufacturer Intermec Inc. would be...

Pages